Cyclin-Dependent Kinase Inhibitor p57
"Cyclin-Dependent Kinase Inhibitor p57" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as well as with BECKWITH-WIEDEMANN SYNDROME.
| Descriptor ID |
D050761
|
| MeSH Number(s) |
D12.644.360.225.700 D12.776.167.187.700 D12.776.476.225.700 D12.776.624.776.355.700
|
| Concept/Terms |
Cyclin-Dependent Kinase Inhibitor p57- Cyclin-Dependent Kinase Inhibitor p57
- Cyclin Dependent Kinase Inhibitor p57
- p57 KIP2 Protein
- KIP2 Protein, p57
- p57KIP2 Protein
- Cyclin-Dependent Kinase Inhibitor 1C
- Cyclin Dependent Kinase Inhibitor 1C
- Cyclin Kinase Inhibitor Protein 2
- CDKN1C Protein
|
Below are MeSH descriptors whose meaning is more general than "Cyclin-Dependent Kinase Inhibitor p57".
Below are MeSH descriptors whose meaning is more specific than "Cyclin-Dependent Kinase Inhibitor p57".
This graph shows the total number of publications written about "Cyclin-Dependent Kinase Inhibitor p57" by people in this website by year, and whether "Cyclin-Dependent Kinase Inhibitor p57" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclin-Dependent Kinase Inhibitor p57" by people in Profiles.
-
ORAI1 Activates Proliferation of Lymphatic Endothelial Cells in Response to Laminar Flow Through Kr?ppel-Like Factors 2 and 4. Circ Res. 2017 Apr 28; 120(9):1426-1439.
-
Down-regulation of the cyclin-dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis. Hepatology. 2016 Mar; 63(3):898-913.
-
Foxp1 maintains hair follicle stem cell quiescence through regulation of Fgf18. Development. 2013 Sep; 140(18):3809-18.
-
Changes in tumor morphology and cyclin-dependent kinase inhibitor expression in metastatic melanoma treated with selective second-generation BRAF inhibitor. Am J Dermatopathol. 2013 Feb; 35(1):125-8.
-
Interleukin-8 reduces post-surgical lymphedema formation by promoting lymphatic vessel regeneration. Angiogenesis. 2013 Jan; 16(1):29-44.
-
Transcription factor TCF4 maintains the properties of human corneal epithelial stem cells. Stem Cells. 2012 Apr; 30(4):753-61.
-
9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema. Circulation. 2012 Feb 21; 125(7):872-82.
-
Lack of sik1 in mouse embryonic stem cells impairs cardiomyogenesis by down-regulating the cyclin-dependent kinase inhibitor p57kip2. PLoS One. 2010 Feb 03; 5(2):e9029.
-
Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. Blood. 2009 Feb 26; 113(9):1892-8.
-
Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes. J Cutan Pathol. 2009 Feb; 36(2):197-205.